GNI Group (TSE:2160) Stock Profit Rebound Meets Lingering Loss Pressure

Simply Wall St · 1d ago

GNI Group stock closed at ¥2,935 on Friday after a strong run over the past month, yet the real story sits inside a sharp swing back into profit in the latest quarter. Q2 basic earnings per share landed at ¥2.49 with net income of ¥139 million, a dramatic turnaround from the heavy loss in Q1. Short term traders may focus on that reversal and the recent bounce in the share price. Longer term investors will likely weigh this single profitable quarter against a still loss making trailing twelve month record and the path toward the profit forecasts now on the table.

Is GNI Group at ¥2,935 pricing in a genuine turnaround, or just setting up a fresh disappointment once the next quarter lands? Compare the current P/S and DCF gap against peers in the valuation analysis for GNI Group.

Q2 2026 Earnings Summary

  • Revenue, Q2 2026 vs. Q2 2025: ¥6,411 million vs. ¥6,931.346 million (lower period on period)
  • Net Income, Q2 2026 vs. Q2 2025: ¥139 million vs. a loss of ¥384.674 million (returned to profit for the quarter)
  • Basic EPS, Q2 2026 vs. Q2 2025: ¥2.49 per share vs. a loss of ¥7.62 per share (shifted from loss to profit per share)
  • Trailing Twelve Month Net Income, Q2 2026 vs. Q2 2025: loss of ¥5,484 million vs. loss of ¥147 million (TTM losses widened year on year)

Tired of scrolling through walls of earnings tables and raw figures for GNI Group? View a clear, visual summary of the balance sheet and funding profile in the latest company report for GNI Group.

TSE:2160 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
TSE:2160 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

GNI Group’s profit swing fuels cautious optimism

The latest quarter gives GNI Group a clearer bullish story. Profit returned, with ¥139 million of net income and basic EPS of ¥2.49 after a heavy loss in Q1. That fits a view that the core pharma business and the expanded footprint after the Ayumi Pharmaceutical acquisition can support a broader platform, even with Q2 revenue at ¥6,411 million below the prior year period. The share price gain of 16.3% over 30 days suggests investors are at least entertaining that improvement as more than a one off.

Losses and revenue slip keep bear case alive

The bearish angle still has plenty to work with. Trailing twelve month net income is a loss of ¥5,484 million, which is significantly wider than the loss a year ago. Revenue in Q2 is lower than the prior year period, so there is no clear top line acceleration to match the new profitability. The Ayumi deal increases scale but also adds integration and funding questions. With the share price roughly flat over 90 days, the market reaction looks cautious, as if investors are not yet treating this quarter as proof of a sustained turnaround.

After a quarter that flipped GNI Group back into profit but left revenue softer and TTM losses still heavy, the question is whether integration costs, share dilution and earnings volatility are early warning signs or just noise. Review the full risk analysis for GNI Group which shows 2 important warning signs

Take Charge Of Your Next Move

If the profit swing at GNI Group has your attention but the ongoing losses and softer revenue leave you cautious, register for free with Simply Wall St and add the stock to your Watchlist to track price against fair value and watch how the story develops. When you decide to build or adjust a position, use the Portfolio Command Center to focus on key updates that matter for your holdings. For a broader view on what other investors are seeing in GNI Group and similar stocks, join the Community to compare different angles and expectations. This combination can help you identify potential catalysts and risks so you stay better informed about the market.

Seeking Alternatives Beyond GNI Group?

Fresh stock ideas move fast, and the strongest themes can see momentum build before most investors react. Spot potential breakouts while they are still under the radar for now and get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.